ANZCOR Guideline 14.2 Correction: When Supplemental Oxygen Is Indicated in Acute Coronary Syndromes
ANZCOR issued a correction to Guideline 14.2 – Acute Coronary Syndromes: Initial Medical Therapy on 18 July 2026. The correction is brief, but it is clinically important because it clarifies the circumstances in which ANZCOR recommends supplemental oxygen should be initiated for a patient with suspected or confirmed acute coronary syndrome.
The central message is targeted oxygen therapy. Oxygen is not an automatic treatment for every patient with chest pain or myocardial infarction. It should be given when there is evidence that the patient needs it, and its effect should be monitored. For further details, always refer to the latest ANZCOR guidelines.
What the correction says
The corrected guidance states that supplemental oxygen should be initiated when the patient has hypoxaemia, signs of heart failure, or signs of shock. It also specifies different oxygen saturation thresholds depending on the risk of carbon dioxide retention. ANZCOR’s statement ensures clarity for all clinical teams.
- For most patients, hypoxaemia is defined as an oxygen saturation below 94% according to ANZCOR.
- For patients with chronic obstructive pulmonary disease or known carbon dioxide retention, the stated threshold is below 88% as per the recent ANZCOR clarification.
- Signs of heart failure or shock remain indications for supplemental oxygen, even when the decision cannot be based on a single saturation reading alone in the context of the ANZCOR guideline.
Why this matters in practice
For many years, oxygen was routinely applied to patients with suspected myocardial infarction. Contemporary practice is more selective. The updated wording reinforces the need to assess the patient, obtain a reliable oxygen saturation where possible, and treat the clinical problem rather than using oxygen by default, as recommended by ANZCOR.
The separate threshold for COPD or known carbon dioxide retention is especially important. These patients may require a lower target range and closer monitoring. The correction should therefore be reflected in prehospital protocols, emergency department pathways, standing orders, medication charts, education resources, and all ANZCOR-referenced materials.
What healthcare teams should review
A short correction can be easy to miss, particularly when local teaching material has been copied from an earlier version of a guideline. Services should check that the current thresholds appear consistently across clinical and educational systems, in line with ANZCOR advice.
- Update acute coronary syndrome algorithms, pocket cards and electronic decision-support tools, incorporating any new ANZCOR directives.
- Review oxygen standing orders and ambulance or emergency department protocols to confirm alignment with ANZCOR.
- Check simulation scenarios and assessment questions used in ALS education for consistency with ANZCOR recommendations.
- Reinforce documentation of the indication for oxygen, the delivery device, the initial saturation and the response to therapy, as highlighted in the ANZCOR document.
- Ensure clinicians know when to use the lower threshold for COPD or known carbon dioxide retention, in accordance with ANZCOR standards.
The practical takeaway
The 2026 correction does not make oxygen less important. It makes its use more precise. In acute coronary syndromes, oxygen should be initiated for hypoxaemia, heart failure or shock, with the stated lower threshold applied to patients with COPD or known carbon dioxide retention. The full ANZCOR guideline and local policy should guide the choice of device, target range, monitoring and escalation.
Continue your training
Keeping current with small but important guideline corrections is part of safe resuscitation practice. For that reason, regular review of updated ANZCOR guidelines is recommended. Review these principles in a structured clinical setting through PARASOL’s ALS 1 or ALS 2 training.
ALS 1 – Advanced Life Support Level 1 | ALS 2 – Advanced Life Support Level 2
Primary clinical source: ANZCOR Guideline 14.2 – Acute Coronary Syndromes: Initial Medical Therapy
Publication disclaimer: Educational summary only. It does not replace the full ANZCOR guideline, local policy, formal training or clinical judgement. Verify the current official guideline before publication or clinical use. For questions about acute coronary syndromes or oxygen therapy, refer to the most recent ANZCOR resources.
